Drug Development & Delivery is a print/online content provider that presents the latest scientific methods in drug development for professionals working in Research & Development, Particle Design, APIs, Pre-formulation, Formulation Development and Analytical Methods.

Covers aspects of the development, production, and evaluation of drugs and pharmaceutical products and highlights both the technical and regulatory facets of industrial pharmacy. Topics addressed within include computerization of production, quality control, export problems, pharmacokinetics and biopharmaceutics, drug regulatory affairs, and successful manufacturing practices.

Written for pharmacology and pharmaceutical industry professionals. Focuses on research topics related to the discovery and development of new therapeutic entities. Publishes original research articles on medicinal chemistry, pharmacology, biotechnology, biopharmaceuticals, toxicology, drug delivery, formulation and pharmacokinetics. Includes brief reports on important and timely new research findings, as well as in-depth review articles. Also features periodic special thematic issues devoted to specific compound classes, new technologies and broad aspects of drug discovery and development.

Background and Format: Medicinal Chemistry provides news, information, resources and jobs listings for those in the medicinal chemical industry. From their UK headquarters near Sudbury, in Suffolk, they run, update and provide web-based information solution for those working within the Life Science and Drug Discovery community. It is part of Technology Networks who were established over 10 years ago with the aim of providing informative websites for life science professionals. Audience and Readership: It is aimed at life science professionals. Monthly Unique Users: Source: Publisher. Ad Rates: For advertising details email promotions@technologynetworks.com Other Information: Blog: www.technologynetworks.com/MedChem/blogs.aspx The team accept press releases and product announcements. These should be emailed as a Microsoft Word attachment or embedded in the email itself and sent directly to the Editor. Images should be sent as separate attachments.

Drug Discovery & Development is an online outlet geared towards pharmaceutical and biotechnology researchers worldwide. Content includes information on recent drug developments at pharmaceutical organizations, breakthroughs in basic and applied research at academic/medical centers, and coverage of research on genomics/proteomics, oncology, neurological diseases, and infectious diseases.

Formerly called Drug Discovery News. Designed for professionals in the pharmaceutical drug industry. Focuses on covering issues, trends and product news that impacts decision makers in the pharmaceutical drug development and discovery arena. News format keeps readers informed about what is happening with partners and competitors, as well as other developments around the globe. Each issue is divided into six departments: Global News, Genomics & Proteomics, Automation & Instrumentation, Informatics, Research & Development and New Products. Press releases should be submitted editorially.

Background & Format: Drug Discovery Today publishes papers on drug discovery provided they are of relevance to drug discovery experts. Covers nature's structure activity relationships, targeted drug delivery systems, new molecular entities, liquid biopsies, organ on a chip technology and engineering microsystems. Drug Discovery Today is published by Elsevier Ltd. Management, commercial and regulatory issues are considered as long as they show how R&D is planned, structured and executed. A media kit is available: advertising.drugdiscoverytoday.com/2018.pdf Impact Factor: 6.88 Journal Ranking: 7.08 Manuscript submission: In general, contributions to Drug Discovery Today are commissioned by the Editors. The publication does, however, accept article proposals. These should be sent to ddt@drugdiscoverytoday.com.

Background and Format: Launched in 1999, Drugs Discovery World (DDW) is published by Edify Digital Media Ltd quarterly and is aimed at CEOs, presidents, owners, group/section leaders, research scientists and consultants for the pharma, biotech and biopharma industries. Covers drug discoveries, business, chemistry, enabling technologies, informatics, precision medicine, screening, therapeutics and white papers. The media pack is available from: www.ddw-online.com/media-info/p146717-rates-and-specs.html Commercial Contact: maria@edifydigitalmedia.com Circulation: Source: Publisher

FDAnews.com covers domestic and international regulatory, legislative and business news and information for executives in industries regulated by the U.S. Food and Drug Administration, including four newsletters: Drug GMP Report, Drug Industry Daily, International Devices & Diagnostics Monitor and The GMP Letter.

FDAnews.com covers domestic and international regulatory, legislative and business news and information for executives in industries regulated by the U.S. Food and Drug Administration, including four newsletters: Drug GMP Report, Drug Industry Daily, International Devices & Diagnostics Monitor and The GMP Letter.